UBS faces scrutiny for allegedly selling complex foreign exchange products, specifically the "Range Target Profit Forward" (RTPF), to clients unaware of the significant risks involved. The Swiss Investor Protection Association reports that many clients, particularly older individuals, have incurred substantial losses due to these products, which have an asymmetrical risk/reward profile. Internal investigations at UBS are ongoing, with oversight from the financial market supervisory authority, Finma, as affected clients seek legal recourse.